Technology/Software Analysts provide an update on the potential impact of Veeva’s migration off Salesforce on an Analyst/Industry conference call to be held on September 19.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on VEEV:
- Salesforce launch of Pharma CRM to elevate debate on Veeva, says Morgan Stanley
- Veeva price target raised to $250 from $227 at Barclays
- Veeva price target raised to $227 from $204 at Truist
- Veeva price target raised to $211 from $180 at Wells Fargo
- Veeva price target raised to $206 from $189 at TD Cowen